Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Delozier

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|November 16, 2010
[Hormonal treatment in breast cancer]T Delozier
Bulletin Du Cancer|November 1, 1991
[Comparative study of adriamycin, epirubicin and mitoxantrone in cancer of the breast. Review of the literature]T Delozier, J C Vernhes
European Journal of Cancer (Oxford, England : 1990)|June 27, 2003
Immunohistochemical study of cell cycle regulatory proteins in intraductal breast carcinomas--a preliminary studyJ Chasle, T Delozier, Y Denoux, et al.
Bulletin Du Cancer|January 1, 1981
[Hydroxy-9-methyl-2-ellipticinium (NSC 264-137) for osseous metastases from breast cancer. A 4 year experience (author's transl)]P Juret, J E Couette, T Delozier, et al.
American Journal of Clinical Oncology|October 1, 1992
Phase II study of tetrahydropyranyl adriamycin (pirarubicin) in elderly patients with advanced breast cancerB Chevallier, L Mignot, T Delozier, et al.
American Journal of Clinical Oncology|July 28, 2001
Epirubicin--docetaxel combination in first-line chemotherapy for patients with metastatic breast cancer: final results of a dose-finding and efficacy studyP Viens, H Roché, P Kerbrat, et al.
Cancer Treatment Reports|November 1, 1982
Hydroxy-9-methyl-2-ellipticinium for osseous metastases from breast cancer: a 5-year experienceP Juret, J F Heron, J E Couette, et al.
Bulletin Du Cancer|May 24, 2001
[Evaluation of predictive factors, particularly the Van Nuys index, of local recurrence in ductal carcinoma in situ of the breast: study of 166 cases with conservative treatment and review of the literature]Y Denoux, J Marnay, H Crouet, et al.
Seminars in Oncology|April 1, 1995
Vinorelbine (Navelbine) in the treatment of breast cancer: the European experienceP Fumoleau, T Delozier, J M Extra, et al.
Lancet (London, England)|February 25, 1978
Sex of first child as a prognostic factor in breast cancerP Juret, J E Couette, T Delozier, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|November 16, 2010
[Hormonal treatment in breast cancer]T Delozier
Bulletin Du Cancer|November 1, 1991
[Comparative study of adriamycin, epirubicin and mitoxantrone in cancer of the breast. Review of the literature]T Delozier, J C Vernhes
European Journal of Cancer (Oxford, England : 1990)|June 27, 2003
Immunohistochemical study of cell cycle regulatory proteins in intraductal breast carcinomas--a preliminary studyJ Chasle, T Delozier, Y Denoux, et al.
Bulletin Du Cancer|January 1, 1981
[Hydroxy-9-methyl-2-ellipticinium (NSC 264-137) for osseous metastases from breast cancer. A 4 year experience (author's transl)]P Juret, J E Couette, T Delozier, et al.
American Journal of Clinical Oncology|October 1, 1992
Phase II study of tetrahydropyranyl adriamycin (pirarubicin) in elderly patients with advanced breast cancerB Chevallier, L Mignot, T Delozier, et al.
American Journal of Clinical Oncology|July 28, 2001
Epirubicin--docetaxel combination in first-line chemotherapy for patients with metastatic breast cancer: final results of a dose-finding and efficacy studyP Viens, H Roché, P Kerbrat, et al.
Cancer Treatment Reports|November 1, 1982
Hydroxy-9-methyl-2-ellipticinium for osseous metastases from breast cancer: a 5-year experienceP Juret, J F Heron, J E Couette, et al.
Bulletin Du Cancer|May 24, 2001
[Evaluation of predictive factors, particularly the Van Nuys index, of local recurrence in ductal carcinoma in situ of the breast: study of 166 cases with conservative treatment and review of the literature]Y Denoux, J Marnay, H Crouet, et al.
Seminars in Oncology|April 1, 1995
Vinorelbine (Navelbine) in the treatment of breast cancer: the European experienceP Fumoleau, T Delozier, J M Extra, et al.
Lancet (London, England)|February 25, 1978
Sex of first child as a prognostic factor in breast cancerP Juret, J E Couette, T Delozier, et al.
Pageof 5